Why did MSB rise 2.6% on 16 Oct 2026?
Mesoblast · Pharmaceuticals, Biotechnology & Life Sciences
$10,000 in MSB shares rose to $10,258 that day. It was down as much as 10.6% during the day before it rose: about a usual day's move for MSB, with twice the usual shares traded.
A sharp sell-off in the Nikkei 225 (-4.9%) likely triggered risk-off selling in MSB, a biotech with significant Japanese market exposure, dragging the stock down well beyond the broader ASX move.
$10,000 in ISO, the ETF that holds the most MSB, gained ▲ $2 that day. In IOZ it was under $1. 17 ETFs hold MSB ›
An ETF is one investment, bought on the stock exchange, that holds many companies at once.
The news
We found no news articles for this move. Headlines link to the publisher.
How the model got there ›
The Nikkei 225 fell nearly 5% (D-1), which is above its 60-day ATR threshold and directionally matches MSB's decline — making it the only signal that satisfies both the direction and proportionality tests. MSB (Mesoblast) has well-documented Japanese regulatory and commercial exposure (e.g. Temcell approval in Japan), giving a credible transmission channel. The ASX Health sector actually rose +1.6% on the same day and peers were flat, ruling out sector rotation or industry-wide selling as the cause, and the absence of any company announcement makes a company-specific catalyst unlikely though not impossible.
Markets that moved with it · 4
Markets that tend to move with this stock, on the same day or the day before.
- S&P 500A market it earns in · the day beforeother way+0.33%
- Nikkei 225A market it earns in · the day beforesame direction−4.90%
- ASX 200 Health CareIts sector · same dayother way+1.59%
- US dollar / Chinese yuanA market it earns in · the day beforesame direction−0.14%
MSB before and after
Mesoblast: price and every explained moveWhat $10,000 in each ETF gained that day
$77 of every $10,000 in ISO was Mesoblast; it rose 2.6%, so $10,000 in ISO gained $2.
- ISO iShares S&P/ASX Small Ordinaries ETF$77 of every $10,000 was Mesoblast▲ $2
- SSO STATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$76 of every $10,000 was Mesoblast▲ $2
- FAIR BetaShares Australian Sustainability Leaders ETF$49 of every $10,000 was Mesoblast▲ $1
- VSO Vanguard MSCI Australian Small Companies Index ETF$31 of every $10,000 was Mesoblast▲ $1
- OZXX Global X Australia ex Financials & Resources ETF$30 of every $10,000 was Mesoblast▲ $1
- IOZ iShares Core S&P/ASX 200 ETF$8 of every $10,000 was Mesoblast · a widely held fundunder $1
- A200 BetaShares Australia 200 ETF$7 of every $10,000 was Mesoblast · a widely held fundunder $1
- VAS Vanguard Australian Shares Index ETF$7 of every $10,000 was Mesoblast · a widely held fundunder $1
9 more ETFs ›
- EX20 BetaShares Australian Ex-20 Portfolio Diversifier ETF$21 of every $10,000 was Mesoblast▲ $1
- GEAR BetaShares Geared Australian Equities Complex ETF$17 of every $10,000 was Mesoblastunder $1
- VETH Vanguard Ethically Conscious Australian Shares ETF$9 of every $10,000 was Mesoblastunder $1
- STW STATE STREET SPDR S&P/ASX 200 ETF$8 of every $10,000 was Mesoblastunder $1
- AYLD Global X S&P/ASX 200 Covered Call Complex ETF$8 of every $10,000 was Mesoblastunder $1
- AUST BetaShares Managed Risk Australian Shares Complex ETF$8 of every $10,000 was Mesoblastunder $1
- A300 Global X Australia 300 ETF$7 of every $10,000 was Mesoblastunder $1
- ROYL BetaShares Global Royalties ETF$7 of every $10,000 was Mesoblastunder $1
- VGE Vanguard FTSE Emerging Markets Shares ETFunder $1 of every $10,000 was Mesoblastunder $1